{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "A Food and Drug Administration committee recommended that doctors have more freedom to use Avandia, a diabetes drug that in 2007 was linked to possible heart problems.", "headline": {"seo": "F.D.A. Advisers Vote to Relax Restrictions on Avandia", "main": "F.D.A. Vote Is Minor Victory for Troubled Diabetes Drug", "print_headline": "F.D.A. Advisers\u2019 Vote Is a Minor Victory for a Troubled Diabetes Drug"}, "abstract": "Food and Drug Administration panel votes to loosen restrictions on controversial diabetes drug Avandia, manufactured by GlaxoSmithKline, saying doctors should have more freedom to prescribe it to patients.", "print_page": "5", "word_count": "900", "_id": "51b10b9546fdbf320e13ab45", "snippet": "A Food and Drug Administration committee recommended that doctors have more freedom to use Avandia, a diabetes drug that in 2007 was linked to possible heart problems.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/06/07/business/fda-advisers-vote-to-lift-restrictions-on-avandia.html", "multimedia": [{"subtype": "wide", "url": "images/2013/06/07/business/FDA/FDA-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/06/07/business/FDA/FDA-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/06/07/business/FDA/FDA-articleLarge.jpg", "height": 1000, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/06/07/business/FDA/FDA-articleLarge.jpg", "xlargeheight": "1000"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/06/07/business/FDA/FDA-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/06/07/business/FDA/FDA-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Food and Drug Administration", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Avandia (Drug)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "GlaxoSmithKline PLC", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Diabetes", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Heart", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"contributor": "Sabrina Tavernise reported from Silver Spring, Md., and Katie Thomas from New York.", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Sabrina", "lastname": "TAVERNISE"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Katie", "lastname": "THOMAS"}], "original": "By SABRINA TAVERNISE and KATIE THOMAS"}, "document_type": "article", "pub_date": "2013-06-07T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "", "headline": {"main": "Can the Human Blueprint Have Owners?", "kicker": "Room For Debate"}, "abstract": "Should companies be allowed to patent genes?", "print_page": null, "word_count": "2067", "_id": "51b13aa946fdbf320e13abc8", "snippet": "Should companies be allowed to patent genes?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/roomfordebate/2013/06/06/can-the-human-blueprint-have-owners/", "multimedia": [], "subsection_name": "Room For Debate", "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": null, "document_type": "blogpost", "pub_date": "2013-06-06T17:48:44Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "The goal is to put the vast collection of data on genetic variations and health into databases open to researchers and doctors all over the world.", "headline": {"main": "Accord Aims to Create Trove of Genetic Data ", "print_headline": "Accord Aims to Create Trove of Genetic Data"}, "abstract": "More than 70 medical, research and advocacy organizations active in 41 countries and including the National Institutes of Health announce that they have agreed to create an organized way to share genetic and clinical information with doctors and researchers worldwide.", "print_page": "6", "word_count": "1071", "_id": "51af506b46fdbf3d9915a4ab", "snippet": "The goal is to put the vast collection of data on genetic variations and health into databases open to researchers and doctors all over the world.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/06/06/health/global-partners-agree-on-sharing-trove-of-genetic-data.html", "multimedia": [{"subtype": "wide", "url": "images/2013/06/06/science/06gene2/06gene-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/06/06/science/06gene2/06gene-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/06/06/science/06gene2/06gene-articleLarge.jpg", "height": 386, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/06/06/science/06gene2/06gene-articleLarge.jpg", "xlargeheight": "386"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/06/06/science/06gene2/06gene-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/06/06/science/06gene2/06gene-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "DNA (Deoxyribonucleic Acid)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Genetics and Heredity", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "National Institutes of Health", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Broad Institute", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Research", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Doctors", "is_major": "Y", "rank": "6", "name": "subject"}, {"value": "Medicine and Health", "is_major": "Y", "rank": "7", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2013-06-06T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Experts are considering ways to speed the approval of new medicines to combat antibiotic-resistant infections, but high costs and safety concerns have complicated their efforts.", "headline": {"seo": "Experts Debate Plan to Speed Antibiotic Development", "main": "Pressure Grows to Create Drugs for \u2018Superbugs\u2019", "print_headline": "Pressure Grows To Create Drugs For \u2018Superbugs\u2019"}, "abstract": "Government officials, drug companies and medical experts are pushing to speed up approval of new antibiotics due to threat of outbreaks of antibiotic-resistant superbugs; critics of speeding up approval process warn of safety concerns.", "print_page": "1", "word_count": "1193", "_id": "51abf63846fdbf3d99159bb8", "snippet": "Experts are considering ways to speed the approval of new medicines to combat antibiotic-resistant infections, but high costs and safety concerns have complicated their efforts.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/06/03/health/experts-debate-plan-to-speed-antibiotic-development.html", "multimedia": [{"subtype": "wide", "url": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-articleLarge.jpg", "height": 395, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-articleLarge.jpg", "xlargeheight": "395"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Antibiotics", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Law and Legislation", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Health and Human Services Department", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "GlaxoSmithKline PLC", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Medicine and Health", "is_major": "Y", "rank": "7", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Barry", "lastname": "MEIER"}], "original": "By BARRY MEIER"}, "document_type": "article", "pub_date": "2013-06-03T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 4, "offset": 0, "time": 38}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}